All Stories

  1. FISSIT (Fistula Surgery in Italy) study: A retrospective survey on the surgical management of anal fistulas in Italy over the last 15 years
  2. Management of Hemorrhoidal Disease in Special Conditions: A Word of Caution
  3. Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy
  4. Do we really need guidelines for HRA during the COVID‐19 pandemic?
  5. Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease
  6. Safety of hospital discharge before return of bowel function after elective colorectal surgery
  7. Intracorporeal or Extracorporeal Ileocolic Anastomosis After Laparoscopic Right Colectomy
  8. Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery
  9. Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study
  10. The Role of High-resolution Anoscopy and Random Biopsies: The Role of Infrared Coagulation vs Active Monitoring in the Treatment of High-grade Squamous Intraepithelial Lesions
  11. Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]
  12. Practice parameters for the diagnosis and treatment of anal intraepithelial neoplasia (AIN) on behalf of the Italian Society of Colorectal Surgery (SICCR)
  13. Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
  14. Progression of LSIL to HSIL or SCC: is anoscopy and biopsy good enough?
  15. Intraoperative air leak test reduces the rate of postoperative anastomotic leak: analysis of 777 laparoscopic left-sided colon resections
  16. Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study
  17. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME)
  18. Association of mechanical bowel preparation with oral antibiotics and anastomotic leak following left sided colorectal resection: an international, multi-centre, prospective audit
  19. Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery
  20. Safety of primary anastomosis following emergency left sided colorectal resection: an international, multi-centre prospective audit
  21. The impact of conversion on the risk of major complication following laparoscopic colonic surgery: an international, multicentre prospective audit
  22. Preoperative stoma site marking: a simple practice to reduce stoma-related complications
  23. Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation
  24. The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer
  25. Analysis of Early and Long-Term Oncologic Outcomes After Converted Laparoscopic Resection Compared to Primary Open Surgery for Rectal Cancer
  26. Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
  27. Current treatments for anal condylomata acuminata
  28. The Thunderbeat and Other Energy Devices in Laparoscopic Colorectal Resections: Analysis of Outcomes and Costs
  29. Image-guided SIB-IMRT for the treatment of anal cancer patients
  30. Pancreatic cancer: sharing a nutrition education project with the patients and their care givers
  31. Start (active surveillance or radical treatment for newly diagnosed patients with a localized, low risk, prostate cancer): an epidemiological study of the Oncology Network of Piemonte and Valle d’Aosta. Update 2017
  32. The ENDOPREDICT® molecular test for breast cancer prognosis: clinical-pathological correlations and therapeutic implications on a selected cohort of patients
  33. The continuing training program of oncology network of Piemonte and Valle d'Aosta: a model for improving the management of oncologic patients
  34. The follow-up and lifestyle (FUCSAM project). Oncology Network of Piemonte and Valle d'Aosta: update 2017
  35. Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer
  36. Reconstruction of the composite defect after extended abdominoperineal resection (eAPR): a clinical experience from Italy
  37. Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective
  38. Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation
  39. Perineal stapled prolapse resection for full-thickness external rectal prolapse: a multicentre prospective study
  40. Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients
  41. Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer
  42. Energy Sources for Laparoscopic Colorectal Surgery: Is One Better than the Others?
  43. Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients
  44. Erratum to: Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement
  45. Conversion of laparoscopic colorectal resection for cancer: What is the impact on short-term outcomes and survival?
  46. Lymphogranuloma venereum in North-West Italy, 2009–2014
  47. Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement
  48. Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost Combined with Concurrent Chemotherapy for the Treatment of Anal Cancer Patients: 4-Year Results of a Consecutive Case Series
  49. YKL-40/c-Met Expression in Rectal Cancer Biopsies Predicts Tumor Regression following Neoadjuvant Chemoradiotherapy: A Multi-Institutional Study
  50. Comments on stapled anopexy and STARR in surgical treatment of haemorrhoidal disease
  51. Laparoscopic versus open resection for transverse colon cancer
  52. Laparoscopic versus open resection for colon cancer: 10-year outcomes of a prospective clinical trial
  53. A novel biomarker‐based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact
  54. Comments on Levic et al.: The outcome of rectal cancer after early salvage TME following TEM compared with primary TME: a case-matched study
  55. Comments on Decision Analysis for Patients With T1 Adenocarcinoma of the Low Rectum
  56. Comments on Midterm Results After Perineal Stapled Prolapse Resection for External Rectal Prolapse
  57. Transrectal sentinel lymph node biopsy for early rectal cancer during transanal endoscopic microsurgery
  58. Bariatric Surgery Improves Urinary Incontinence but Not Anorectal Function in Obese Women
  59. Value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: an update of the series and a review of the literature
  60. Surgical scar endometriosis
  61. Metastatic lymph node ratio as a prognostic factor after laparoscopic total mesorectal excision for extraperitoneal rectal cancer
  62. The treatment of squamous anal carcinoma: guidelines of the Italian society of colo-rectal surgery
  63. Rectal lymphogranuloma venereum
  64. Role of Positron Emission Tomography-Computed Tomography in the Management of Anal Cancer
  65. Perineal Stapled Prolapse Resection for Complete External Rectal Prolapse: Preliminary Experience and Literature Review
  66. Long-term functional results and quality of life after transanal endoscopic microsurgery
  67. Letter to the Editor
  68. Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Inguinal Node Metastases in Patients With Anal Cancer
  69. Surgical Treatment of Anal Condylomata Acuminata
  70. YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival
  71. Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial
  72. Sentinel lymph node biopsy in anal cancer: A review
  73. Lymphoscintigraphic localization of sentinel node in early colorectal cancer: Results of a monocentric study
  74. The Role of Early Radiological Studies After Gastric Bariatric Surgery
  75. Outcome of Vertical Banded Gastroplasty